Centre de Lutte Contre le Cancer - Institut Bergonie

Bordeaux, Aquitaine 33076

0 studies enrolling now · 1 studies all time

What they study most

Myeloid Leukemia, Chronic, Chronic Phase

Studies at this site

• Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses — Completed